Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 70026 - 70050 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	CPE	1363	downregulated	Silicon Dioxide analog results in decreased expression of CPE mRNA	4q32.3	A24195
Silicon dioxide	Approved	CPE	1363	upregulated	Silicon Dioxide analog results in increased expression of CPE mRNA	4q32.3	A24194
Silicon dioxide	Approved	CPE	1363	downregulated	Silicon Dioxide results in decreased expression of CPE mRNA	4q32.3	A24196
Silicon dioxide	Approved	CPEB3	22849	downregulated	Silicon Dioxide results in decreased expression of CPEB3 mRNA	10q23.32	A24196
Silicon dioxide	Approved	CPLX2	10814	downregulated	Silicon Dioxide analog results in decreased expression of CPLX2 mRNA	5q35.2	A24195
Silicon dioxide	Approved	CPN1	1369	downregulated	Silicon Dioxide analog results in decreased expression of CPN1 mRNA	10q24.2	A24195
Silicon dioxide	Approved	CPNE4	131034	downregulated	Silicon Dioxide analog results in decreased expression of CPNE4 mRNA	3q22.1	A24195
Silicon dioxide	Approved	CPNE5	57699	downregulated	Silicon Dioxide analog results in decreased expression of CPNE5 mRNA	6p21.2	A24195
Silicon dioxide	Approved	CPO	130749	upregulated	Silicon Dioxide analog results in increased expression of CPO mRNA	2q33.3	A24194
Silicon dioxide	Approved	CPPED1	55313	upregulated	Silicon Dioxide results in increased expression of CPPED1 mRNA	16p13.12	A24196
Silicon dioxide	Approved	CPQ	10404	downregulated	Silicon Dioxide analog results in decreased expression of CPQ mRNA	8q22.1	A24195
Silicon dioxide	Approved	CPT1A	1374	downregulated	Silicon Dioxide results in decreased expression of CPT1A mRNA	11q13.3	A24196
Silicon dioxide	Approved	CPXM2	119587	upregulated	Silicon Dioxide analog results in increased expression of CPXM2 mRNA	10q26.13	A24194
Silicon dioxide	Approved	CRCT1	54544	upregulated	Silicon Dioxide results in increased expression of CRCT1 mRNA	1q21.3	A24196
Silicon dioxide	Approved	CREB3L3	84699	upregulated	Silicon Dioxide analog results in increased expression of CREB3L3 mRNA	19p13.3	A24195
Silicon dioxide	Approved	CREB5	9586	upregulated	Silicon Dioxide analog results in increased expression of CREB5 mRNA	7p15.1-p14.3	A24194 A24195
Silicon dioxide	Approved	CREB5	9586	upregulated	Silicon Dioxide results in increased expression of CREB5 mRNA	7p15.1-p14.3	A24197 A24196
Silicon dioxide	Approved	CRELD1	78987	downregulated	Silicon Dioxide analog results in decreased expression of CRELD1 mRNA	3p25.3	A24195
Silicon dioxide	Approved	CRH	1392	upregulated	Silicon Dioxide analog results in increased expression of CRH mRNA	8q13.1	A24195
Silicon dioxide	Approved	CRHBP	1393	upregulated	Silicon Dioxide analog results in increased expression of CRHBP mRNA	5q13.3	A24194
Silicon dioxide	Approved	CRHR2	1395	upregulated	Silicon Dioxide analog results in increased expression of CRHR2 mRNA	7p14.3	A24195
Silicon dioxide	Approved	CRIP2	1397	downregulated	Silicon Dioxide analog results in decreased expression of CRIP2 mRNA	14q32.33	A24195
Silicon dioxide	Approved	CRIP3	401262	downregulated	Silicon Dioxide analog results in decreased expression of CRIP3 mRNA	6p21.1	A24195
Silicon dioxide	Approved	CRISPLD2	83716	downregulated	Silicon Dioxide analog results in decreased expression of CRISPLD2 mRNA	16q24.1	A24194
Silicon dioxide	Approved	CRLF3	51379	upregulated	Silicon Dioxide analog results in increased expression of CRLF3 mRNA	17q11.2	A24195

Displaying entries 70026 - 70050 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability